Stephen David Prior, Chief Strategy Officer: AN2 Therapeutics ANTX Sell · Filed 25/11/06

Trade details

Type: Insider sale
Amount: $872.1
Shares · price: 765 sh · $1.14 a share
Held after: 65,548 sh
Stock: AN2 Therapeutics ANTX
Person: Stephen David PriorChief Strategy Officer
Trade date: 25/11/04
Filed: 25/11/06
Days to filing: 2 days

Sold 1.2% of holdings

Share of holding sold: 1.2%

AN2 Therapeutics trades, last 26 weeks

What else happened in AN2 Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/05~25/12/04

Stephen David Prior's recent trades

Stephen David PriorChief Strategy Officer
SellAN2 Therapeutics
Sell
AN2 Therapeutics
ANTX
$3,604
3,604 sh
$3,604
Filed 01/07
Traded 01/05
Stephen David PriorChief Strategy Officer
SellAN2 Therapeutics
Sell
AN2 Therapeutics
ANTX
$2,887
2,858 sh
$2,887
Filed 01/07
Traded 01/06
Stephen David PriorChief Strategy Officer
SellAN2 Therapeutics
Sell
AN2 Therapeutics
ANTX
$2,719
2,029 sh
$2,719
Filed 25/01/07
Traded 25/01/03